Regenerative Bio
Signal active
Organization
Contact Information
Overview
Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing, Regenerative Bio combines AI pharmaceutical-related technologies with biology to explore ingredients, formulations and therapies with anti-aging effects, and solve the problems caused by aging.
About
Industries
Biotechnology, Artificial Intelligence (AI), Health Care, Pharmaceutical
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Regenerative Bio headquartered in United States, North America, operates in the Biotechnology, Artificial Intelligence (AI), Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $160.0M in funding across 16 round(s). With a team of 11-50 employees, Regenerative Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Angel Round - Regenerative Bio, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
6
Lead Investors
0
Total Funding Amount
$10.0M
Details
1
Regenerative Bio has raised a total of $10.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 10.0M |
Investors
Regenerative Bio is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Taihill Venture | - | FUNDING ROUND - Taihill Venture | 10.0M |
| Wei Guo | - | FUNDING ROUND - Wei Guo | 10.0M |
| Regenerative Bio | - | FUNDING ROUND - Regenerative Bio | 10.0M |
| UpHonest Capital | - | FUNDING ROUND - UpHonest Capital | 10.0M |
Recent Activity
There is no recent news or activity for this profile.